This is a registry study in adults with spasticity to determine onabotulinumtoxinA use in clinical practice. Treatment will be administered in accordance with physician standard practice. All treatment decisions lie with the physician.
Study Type
OBSERVATIONAL
Enrollment
744
onabotulinumtoxinA administered according to physician standard of care. All treatment decisions lie with the physician.
Percentage of Patients Reporting Satisfaction with Treatment
Time frame: 5 Weeks
Percentage of Health Care Providers Reporting Satisfaction with Treatment
Time frame: 12 Weeks
Physical Functioning on a 5-Point Scale
Time frame: 5 Weeks
Severity of Pain on an 11-Point Scale
Time frame: 5 Weeks
Disability Assessment on a 4-Point Scale
Time frame: 12 Weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Loma Linda University School Of Medicine
Loma Linda, California, United States
MS Center of California
Newport Beach, California, United States
Sutter Health General Hospital
Sacramento, California, United States
Design Neuroscience Center
Doral, Florida, United States
Brooks Rehabilitation Hospital
Jacksonville, Florida, United States
Emerald Coast Center for Neurological Disorders
Pensacola, Florida, United States
Gil, Ramon A.
Port Charlotte, Florida, United States
Kernan Hospital
Baltimore, Maryland, United States
MedTechnical, PLLC
Silver Spring, Maryland, United States
Michigan Institute for Neurological Disorders
Farmington Hills, Michigan, United States
...and 45 more locations